Clinical trials
Cardiotoxicity trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 6 |
| Terminated | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Groupe Hospitalier Pitie-Salpetriere | 5 |
| Assistance Publique - Hôpitaux de Paris | 4 |
| University Hospital, Brest | 2 |
| University Hospital, Caen | 2 |
| Centre Paul Strauss | 1 |
| GERCOR - Multidisciplinary Oncology Cooperative Group | 1 |
| Institut de cancérologie Strasbourg Europe | 1 |
| Sophie JACOB | 1 |
| University Hospital Muenster | 1 |
| University Hospital, Bordeaux | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiotoxicity | 21 |
| Neoplasms | 5 |
| Breast Neoplasms | 4 |
| Heart Diseases | 3 |
| Heart Failure | 3 |
| Arrhythmias, Cardiac | 2 |
| Atrial Fibrillation | 2 |
| Hematologic Neoplasms | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Acute Coronary Syndrome | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.